Search Count: 12
 |
Crystal Structure Of Sars-Cov-2 Main Protease (Mpro)In Complex With Inhibitor Avi-3318
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.96 Å Release Date: 2025-07-23 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: A1BTM |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-07-23
Ligands: A1BTM
 |
Crystal Structure Of Sars-Cov-2 Main Protease (Mpro) In Complex With Inhibitor Avi-4692
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.84 Å Release Date: 2025-07-23 Classification: HYDROLASE Ligands: A1BVT, A1BTO |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-07-23
Ligands: A1BVT, A1BTO
 |
Crystal Structure Of Sars-Cov-2 Main Protease (Mpro)In Complex With Inhibitor Avi-4516
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.35 Å Release Date: 2025-07-23 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: A1BTP, EDO |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-07-23
Ligands: A1BTP, EDO
 |
Crystal Structure Of Sars-Cov-2 Main Protease (Mpro) Variant Q192T In Complex With Inhibitor Avi-4303
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.57 Å Release Date: 2025-07-23 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: EDO, A1BTN, CL |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2025-07-23
Ligands: EDO, A1BTN, CL
 |
Virtual Screening For Novel Sars-Cov-2 Main Protease Non-Covalent And Covalent Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2023-07-05 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: U0R |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-07-05
Ligands: U0R
 |
Virtual Screening For Novel Sars-Cov-2 Main Protease Non-Covalent And Covalent Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.17 Å Release Date: 2023-06-28 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: TKX |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-06-28
Ligands: TKX
 |
Virtual Screening For Novel Sars-Cov-2 Main Protease Non-Covalent And Covalent Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.09 Å Release Date: 2023-06-28 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: TNI |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-06-28
Ligands: TNI
 |
Virtual Screening For Novel Sars-Cov-2 Main Protease Non-Covalent And Covalent Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2023-06-28 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: U1J |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-06-28
Ligands: U1J
 |
Virtual Screening For Novel Sars-Cov-2 Main Protease Non-Covalent And Covalent Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:1.98 Å Release Date: 2023-06-28 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: U1R |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-06-28
Ligands: U1R
 |
Virtual Screening For Novel Sars-Cov-2 Main Protease Non-Covalent And Covalent Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.45 Å Release Date: 2023-06-28 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: U26 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-06-28
Ligands: U26
 |
Virtual Screening For Novel Sars-Cov-2 Main Protease Non-Covalent And Covalent Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.12 Å Release Date: 2023-06-28 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: U2B |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-06-28
Ligands: U2B
 |
Virtual Screening For Novel Sars-Cov-2 Main Protease Non-Covalent And Covalent Inhibitors
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.59 Å Release Date: 2023-06-28 Classification: VIRAL PROTEIN,HYDROLASE/INHIBITOR Ligands: U2I |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2023-06-28
Ligands: U2I